Cargando…
Tapentadol Prolonged Release: A Review in Pain Management
Tapentadol prolonged release (tapentadol PR) [Palexia(®) SR in EU] is a long-acting tablet formulation of the strong central analgesic tapentadol, which acts as both a μ-opioid receptor (MOR) agonist and a noradrenaline reuptake inhibitor. Tapentadol PR is approved for chronic pain in various countr...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422986/ https://www.ncbi.nlm.nih.gov/pubmed/30471002 http://dx.doi.org/10.1007/s40265-018-1007-2 |